Provided by Tiger Trade Technology Pte. Ltd.

VanEck Healthcare TruSector ETF

29.36
-0.0920-0.31%
Post-market: 29.34-0.0191-0.07%16:10 EDT
Volume:158
Turnover:5K
Market Cap:587.18K
PE:- -
High:29.36
Open:29.34
Low:29.34
Close:29.45
52wk High:30.68
52wk Low:24.78
Shares:20.00K
Float Shares:20.00K
Volume Ratio:0.16
T/O Rate:0.79%
Dividend:0.08
Dividend Rate:0.29%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Retension Pharmaceuticals, TRex Bio File for US IPO as Biotech Momentum Continues

Reuters
·
7 hours ago

3 ‘Strong Buy’ Dividend Aristocrat Stocks to Generate Steady Cash

TIPRANKS
·
9 hours ago

Sector Update: Healthcare

MT Newswires Live
·
9 hours ago

Eli Lilly reports full FDA approval of Inluriyo combo for certain breast cancers

TIPRANKS
·
11 hours ago

US FDA Approves Lilly Inluriyo-Verzenio Combo for ESR1-Mutated Metastatic Breast Cancer

Reuters
·
11 hours ago

U.S. FDA Approves Inluriyo (Imlunestrant) in Combination with Verzenio (Abemaciclib) for Adults with Er+, Her2-, Esr1-Mutated Advanced or Metastatic Breast Cancer

THOMSON REUTERS
·
11 hours ago

Eli Lilly - Inluriyo with Verzenio NOW Available in the United States

THOMSON REUTERS
·
11 hours ago

AbbVie presents new Vraylar data at Psych Congress 2026

TIPRANKS
·
Yesterday

AbbVie Says Real-World Studies Show Vraylar Improves Symptoms in MDD, Bipolar I Depression

Reuters
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Yesterday

Merck Says EU CHMP Backs Keytruda-Padcev Perioperative Use in Resectable Muscle-Invasive Bladder Cancer

Reuters
·
Yesterday

Merck & Co - Final Ec Decision Expected by Q4 2026

THOMSON REUTERS
·
Yesterday

Merck Receives Positive EU Chmp Opinion for Keytruda® (Pembrolizumab) Plus Padcev® (Enfortumab Vedotin-Ejfv) as Perioperative Treatment for Adults with Resectable Muscle-Invasive Bladder Cancer (Mibc)

THOMSON REUTERS
·
Yesterday

Merck Launches Your Hive of Whole Health to Support Whole Person Care for People Living with Hiv

THOMSON REUTERS
·
Yesterday

All 50 States Sign up for Trump's Medicaid Most-Favored-Nation Plan

Reuters
·
Yesterday

When Weight Loss Isn't the Goal of Taking a GLP-1

Dow Jones
·
Yesterday

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Yesterday

PepsiCo Adds Johnson & Johnson CEO Joaquin Duato to Board, Names Him to Audit Committee

Reuters
·
Yesterday

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?

Dow Jones
·
Yesterday